FOI release

MHRA Yellow Card - Interactive Drug Analysis Profiles

Some or all of the information requested was not provided because we determined that the cost to do so would exceed the appropriate limit.

Case reference FOI2025/00454

Received 11 May 2025

Published 23 June 2025

Request

I am writing to inquire about the iDAP (Interactive Drug Analysis Profiles) that you provide. I am interested in understanding the internal data preprocessing and cleaning methods and pathways employed before the adverse drug reaction (ADR) data is made available through iDAP. If possible, I would greatly appreciate any information you can provide regarding this process.

Response

see attached

Documents

• FOI2025_00454 redacted for publication.pdf (123.4 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.